Stryker Corporation Overview
Pro stress-test →Stryker Corporation designs, manufactures, and markets medical equipment, instruments, consumable supplies, and implantable devices, including hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Having surpassed $25 billion in revenue, Stryker enters 2026 with significant momentum and is poised to continue delivering growth at the high end of MedTech.
Strategic Profile
Pro stress-test →Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. The company demonstrates solid financial health with a current ratio of 1.85 and a debt-to-equity ratio of 0.76.
Competitive Landscape
Pro stress-test →Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Main competitors include Zimmer Biomet and Smith & Nephew in orthopedics, as well as broader medical device competitors like Johnson & Johnson and Medtronic in surgical and patient care solutions.
Industry Context
Stryker Corporation operates in Medical Devices & Equipment Manufacturing.
Key facts
Founded: 1941 · Headquarters: Portage, US · Revenue: $25.1B · Market cap: $138B